Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
JPT1 pseudogene 1 (JPT1P1) is a non-protein-coding genomic element derived from the JPT1 gene, cataloged as a pseudogene in genomic databases. Pseudogenes, including JPT1P1, generally lack protein-coding function due to sequence mutations or deletions, but they can sometimes regulate the expression of their parental gene or participate in disease processes via transcriptional or post-transcriptional mechanisms. There is no evidence that JPT1P1 is a functional drug target or is directly involved in disease; most research focuses on its protein-coding counterpart, JPT1. Some pseudogenes indirectly influence cancer and other diseases by acting as microRNA sponges or through other regulatory effects, but there is no published work specifically associating JPT1P1 with such functional roles. If your intent is to retrieve druggable or actionable information, you should search for JPT1 rather than JPT1P1.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on JPT1 pseudogene 1 (JPT1P1).